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Nucleotide excision repair consists of removal of the
damaged nucleotide(s) from DNA by dual incision of the
damaged strand on both sides of the lesion, followed by
filling of the resulting gap and ligation. In humans,
14–16 polypeptides are required for the dual incision
step. We have purified the required proteins to homoge-
neity and reconstituted the dual incision activity (exci-
sion nuclease) in a defined enzyme/substrate system.
The system was highly efficient, removing >30% of the
thymine dimers under optimal conditions. All of the six
fractions that constitute the excision nuclease were re-
quired for dual incision of the thymine dimer substrate.
However, when a cholesterol-substituted oligonucleo-
tide was used as substrate, excision occurred in the
absence of the XPC-HHR23B complex, reminiscent of
transcription-coupled repair in the XP-C mutant cell
line. Replication protein A is absolutely required for
both incisions. The XPG subunit is essential to the for-
mation of the preincision complex, but the repair com-
plex can assemble and produce normal levels of 3*-inci-
sion in the absence of XPF-ERCC1. Kinetic experiments
revealed that the 3*-incision precedes the 5*-incision.
Consistent with the kinetic data, uncoupled 5*-incision
was never observed in the reconstituted system. Two
forms of TFIIH were used in the reconstitution reaction,
one containing the CDK7-cyclin H pair and one lacking
it. Both forms were equally active in excision. The ex-
cised oligomer dissociated from the gapped DNA in a
nucleoprotein complex. In total, these results provide a
detailed account of the reactions occurring during dam-
age removal by human excision nuclease.
DNA repair reactions play an important role in preventing
cancer development in humans. Individuals with defects in
mismatch repair have high incidence of internal cancers
(Kolodner and Alani, 1994; Modrich and Lahue, 1996). Simi-
larly, individuals with defective nucleotide excision repair spe-
cific for bulky DNA lesions suffer from xeroderma pigmento-
sum (XP),1 which manifests itself by extremely high incidence
of actinic cancers, increased incidence of cancers of internal
organs, and mental and neurological abnormalities (Cleaver
and Kraemer, 1989; Friedberg et al., 1995). In humans, muta-
tions in seven genes, XPA through XPG, cause XP associated
with defective excision repair (Cleaver and Kraemer, 1989). In
addition, genetic and biochemical studies with rodent cell lines
and radiation-sensitive Saccharomyces cerevisiae mutants and
repair assays with cell-free extracts have implicated several
other proteins in the excision step of nucleotide excision repair.
In particular, it has been found that the general transcription
factor TFIIH (five to eight subunits) (Drapkin et al., 1994;
Schaeffer et al., 1994; Wang et al., 1994) and the trimeric
replication protein A (RPA or HSSB) are absolutely required
for the dual incision step of excision repair (Mu et al., 1995).
Recently, excision repair has been reconstituted from highly
purified repair factors in humans (Mu et al., 1995; Aboussekhra
et al., 1995) and in the highly analogous S. cerevisiae system
(Guzder et al., 1995). It has been reported that in both systems
the following six fractions are necessary and sufficient for the
dual incision activity (Mu et al., 1995; Guzder et al., 1995): XPA
(Rad14), RPA, TFIIH (five to eight polypeptides including XPB
(Rad25) and XPD (Rad3)), XPC-HHR23B (Rad4-Rad23), XPG
(Rad2), and XPF-ERCC1 (Rad1-Rad10). In this study, we have
obtained the six fractions of human excision nuclease (exc-
inuclease) free of contaminants and have used synthetic sub-
strates containing either a thymine dimer (T,.T) or a choles-
terol molecule at a predetermined site to investigate the
reaction mechanism of the excision nuclease. Our results re-
veal that XPC-HHR23B, in contrast with the other factors that
are necessary for all excision reactions, is required for excision
of the thymine dimer, but not for excision of a particular cho-
lesterol lesion. In this study, it is also demonstrated that the
39-incision made by XPG (Harrington and Lieber, 1994;
O’Donovan et al., 1994; Matsunaga et al., 1995) precedes the
59-incision made by XPF-ERCC1 (Matsunaga et al., 1995) and
that the CDK-activating kinase constituents (CDK7 and cyclin
H) that are present in TFIIH as integral subunits do not inter-
fere with the repair activity of TFIIH and are not required for
repair. Following the dual incision, the 27–29-nucleotide-long
excised oligomers (Huang et al., 1992) are released in a complex
with repair proteins, while the gapped DNA remains com-
plexed with a separate set of repair proteins.
EXPERIMENTAL PROCEDURES
Purification of Human Nucleotide Excision Repair Proteins—Four-
hundred liters of HeLa S3 cells were purchased from Cellex Biosciences
(Minneapolis, MN), and the cell-free extract was prepared according to
Manley et al. (1980). The purification scheme in this study was different
from our previous design (Mu et al., 1995) in that two additional
chromatographic steps, Affi-Gel blue (Bio-Rad) and SP-Sepharose
(Pharmacia Biotech Inc.), were used following the first DE52 column
(Whatman) chromatagraphy step. The Affi-Gel blue column chromatog-
raphy step was conducted as described by Park et al. (1995b). TFIIH
and XPC were found in the gradient elution prior to the 1.5 M NaSCN
wash, whereas XPG, RPA, and a minority of XPF-ERCC1 were identi-
fied in the fractions eluted with 1.5 M NaSCN by immunoblotting. The
majority (.60%) of XPF-ERCC1 came off the Affi-Gel blue column at
0.2–0.4 M KCl and was further purified to near homogeneity as de-
scribed elsewhere (Park et al., 1995b). The purified complex shown in
Fig. 1A reconstituted excision nuclease when combined with other
factors. However, due to the limited amount of the purest XPF-ERCC1
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fraction, some of the experiments were conducted with the XPF-ERCC1
fraction from the penultimate step of purification (Park et al., 1995b).
To further purify XPG, the 1.5 M NaSCN-eluted fractions were loaded
onto an SP-Sepharose column (2.5 3 30 cm). A 700-ml gradient of
0.1–0.45 M KCl in storage buffer (25 mM Hepes/KOH, pH 7.9, 100 mM
KCl, 12 mM MgCl2, 0.5 mM EDTA, 2 mM dithiothreitol, 17% glycerol)
was used to elute this column at 1.3 ml/min. Unlike RPA and XPF-
ERCC1, which came in the flow-through fraction, XPG was found to
elute at ;0.4 M KCl by immunoblotting. These XPG-containing frac-
tions were subsequently resolved to give homogeneous XPG using pro-
cedures modified from Habraken et al. (1994).
As to TFIIH and XPC, the fractions from the Affi-Gel blue column
containing these factors were applied onto the same SP-Sepharose
column and eluted with a 1-liter gradient of 0.1–1.0 M KCl in storage
buffer. XPC eluting at ;0.3 M KCl was separated from TFIIH eluting at
;0.16 M KCl. Subsequently, pure XPC as judged by silver-stained
SDS-PAGEwas obtained using the procedures of Masutani et al. (1994).
Subsequent TFIIH purification was performed similarly to our previous
procedure (Mu et al., 1995), except that Mono S chromatography (HR
5/5, Pharmacia Biotech Inc.) was added as the final step. This 1-ml
column was eluted at 0.5 ml/min using a 35-ml gradient of 50–300 mM
KCl in buffer C (20 mM Tris-HCl, pH 7.9, 0.1 mM EDTA, 19% glycerol,
10 mM b-mercaptoethanol), and 1-ml fractions were collected. Each
fraction was concentrated using an Amicon stirred cell, dialyzed in
storage buffer, and stored at 280 °C.
The XPA cDNA tagged with His6 using the pRSET vector (Invitro-
gen) was overexpressed in Escherichia coli strain DR153 (Park and
Sancar, 1993) and purified by a modified procedure of Jones and Wood
(1993). The DNA construct bearing the three-subunit human RPA was
obtained from Dr. M. Wold (University of Iowa), and the recombinant
RPA of apparent homogeneity was prepared from E. coli according to
Henricksen et al. (1994).
Substrate for Excision/Incision Assays—The substrate was a 140-
base pair duplex containing either a cholesterol molecule attached at
position 70 or a cyclobutane thymine dimer (T,.T) at positions 74 and
75 in the opposite strand (see Fig. 2, D and E). The complete nucleotide
sequence of the cholesterol-containing substrate has been published
(Matsunaga et al., 1995). However, the nucleotide sequence surround-
ing the thymine dimer is different from that of the cholesterol substrate,
and the difference is as shown in Fig. 2D. Depending on the type of
experiment performed, we used 59-terminally or internally 32P-radiola-
beled substrates. Internally radiolabeled duplex substrates were made
from six oligomers, whereas end-labeled substrates were assembled
from either two oligomers of 140 nucleotides or the same six oligomers
used for internally labeled substrate (Matsunaga et al., 1995). Two
kinds of cholesterol-containing oligomers were used in this study. Cho-
lesterol-A (see Fig. 2A) was from Midland Certified Reagents (Midland,
TX), and cholesterol-B was from Operon Biotechnologies, Inc. (Alame-
da, CA). Cyclobutane thymine dimer-containing oligomer was obtained
from Dr. J.-S. Taylor (Washington University, St. Louis, MO) prepared
by the method of Smith and Taylor (1993).
Excision/Incision Assays—The excision assays that measure the ex-
cised damage-containing oligomer by dual incisions of the human DNA
repair excision nuclease were conducted as described previously
(Huang et al., 1992; Huang and Sancar, 1994; Mu et al., 1995; Matsu-
naga et al., 1995). The excision reaction was incubated at 30 °C for 1 h
unless indicated otherwise. The amount of each purified repair factor
for a typical 25-ml excision reaction is as follows: XPA, 20 ng; TFIIH, 1–2
ng; XPC, 7 ng; XPG, 1–2 ng; XPF-ERCC1, 1–2 ng; and RPA, 300 ng.
Quantitation of the excised oligomers of 23–30 nucleotides and the
oligomers corresponding to single incision was achieved by scanning the
sequencing gel using a PhosphorImager (Molecular Dynamics, Inc.).
Pull-down Assays/Release of Excised Oligomer and Formation of Pre-
incision Complex—The recessed 39-end of internally radiolabeled duplex
substrate was filled with dATP-biotin (Life Technologies, Inc.) using the
standard protocol. Incorporation of dATP-biotin was judged to be .90%
using a 5% denaturing polyacrylamide gel. Following incubation for 1 h
with either reconstituted excision nuclease or cell-free extract (CFE). The
streptavidin bead-bound substrate DNA (and therefore the proteins that
interacted with the substrate DNA) was collected using a magnetic par-
ticle concentrator (Dynal, Inc.) and washed twice with 100 ml of 1 3
excision reaction buffer (30 mM Hepes/KOH, pH 7.9, 50 mM KCl, 4 mM
MgCl2, 2 mM ATP, 200 mg/ml bovine serum albumin). To determine if the
excised oligomers could be pulled down by the beads, both the magnetic
bead-bound material and unbound material were deproteinized, ethanol-
precipitated, and analyzed using 8% denaturing polyacrylamide gels.
Excision reactions to isolate preincision complex were performed with the
biotinylated internally radiolabeled substrates using 50 mg of repair-
deficient mutant cell extract. To rule out the possibility that repair pro-
teins were pulled down via nonspecific interactions with substrate DNA,
100 ng of pBR322 plasmid were included as competitor DNA for each
experiment. After the 1-h 30 °C incubation, the reaction mixture was
placed in the magnetic particle concentrator in order to collect streptavi-
din bead-bound DNA-protein complex. Subsequently, the bead-boundma-
terial was subjected to a second excision reaction in the presence of either
a repair-deficient mutant cell extract (50 mg) of a different complementa-
tion group or the corresponding purified repair factor. The products of this
second excision reaction were then examined using 8% denaturing poly-
acrylamide gels.
RESULTS
Excision Repair with Purified Proteins—It has been reported
that the mixture of highly purified fractions containing XPA,
RPA, TFIIH, XPC-HHR23B, XPG, and XPF-ERCC1 was capa-
ble of excising DNA lesions in 28-nucleotide-long oligomers
from synthetic substrates (Mu et al., 1995) or nicking heavily
UV-irradiated plasmid DNA (Aboussekhra et al., 1995). How-
ever, some of the fractions used in these reconstitutions con-
tained minor contaminants, and hence, the requirement for
additional proteins could not be eliminated (Mu et al., 1995). In
fact, it was proposed that an unidentified factor that copurified
with XPF-ERCC1 was needed for specific nicking (Aboussekhra
et al., 1995). Furthermore, damage-specific nicking was ob-
served in the absence of RPA (Aboussekhra et al., 1995), raising
the possibility that RPA was not essential for nicking, but
played a stimulatory role. In addition, in both reconstitution
systems, only ;1% of the lesions were excised, leading one to
suspect that additional factors were needed for optimal
activity.
To address the questions raised by these studies, we have
purified all six repair factors extensively to obtain proteins of
high purity as shown in Fig. 1A. The mixture of these fractions
excised both thymine dimer and two types of cholesterol lesions
(Fig. 2) from DNA in the form of 24–30-nucleotide-long dam-
age-carrying oligomers with high efficiency. Both lesions were
excised efficiently and to about the same extent (20–30%) in
5–7 h (Fig. 3). Thus, it appears that the efficiency of the defined
excision repair system is comparable to the in vivo reaction,
suggesting that it is unlikely that additional factors are re-
quired for optimal excision. The poor excision efficiency ob-
tained in our previous reconstitution may be attributed to the
disproportionate amount of the factors. For instance, we have
found that increasing the amount of XPC-HHR23B in the re-
action mixture from 15 to 60 ng can severely inhibit excision
(data not shown).
FIG. 1. The six factors of human excision nuclease. A, silver-
stained SDS-PAGE of the six factors. XPA and RPA are recombinant
proteins purified from E. coli. The other factors were purified from
HeLa cells. The amounts of individual factors analyzed by SDS-PAGE
were as follows: XPA, 100 ng; TFIIH, 50 ng; XPC, 40 ng; XPG, 40 ng;
XPF-ERCC1, 30 ng; and RPA, 800 ng. B, lack of XPC in the five
fractions that excise cholesterol damage. Ten-fold the amount of the
three HeLa cell-derived fractions used in the reconstitution assays was
mixed and separated by SDS-PAGE (10%) and subjected to immuno-
blotting using the ECL detection system according to the manufacturer
(Amersham Corp.) (lane 1). Lane 2 contained 1.5 ng of XPC protein as
a positive control (,10% of this amount can be detected).
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Requirement for Individual Factors in Dual Incision—Previ-
ously, we have shown that all six factors (Fig. 1A) are required
for excision (Mu et al., 1995). However, that study did not
address the question of whether or not single incision occurs
when one or more of these six factors are omitted. Particularly,
the report of Aboussekhra et al. (1995) that a reduced propor-
tion of nicked damaged molecules was observed when RPA was
absent suggested that either the 39- or the 59-nick can take
place without RPA. Hence, we conducted excision/incision as-
says using the defined excision nuclease system and a 140-base
pair duplex with a single thymine dimer under the conditions
where one of factors was omitted from the complete system. In
this assay, 59-nick without 39-incision (uncoupled 59-incision) is
expected to generate fragments in the size range of 88–92
nucleotides, whereas uncoupled 39-incision is predicted to gen-
erate fragments 79–82 nucleotides in length (Huang et al.,
1992; Matsunaga et al., 1995). The results of this experiment
are shown in Fig. 4A. In the complete system, the 27–30-
nucleotide-long excision products and, to a lesser extent, the
79–82-nucleotide fragments due to uncoupled 39-incision ap-
peared (Fig. 4A, lane 3). Under these experimental conditions,
;20% of the 39-incisions were not coupled to 59-incision. Omis-
sion of any factor, with the exception of XPF-ERCC1, com-
pletely abolished both 59- and 39-incisions. Significantly, omis-
sion of XPF-ERCC1 gave rise to single incision at the 39-side of
the lesion exclusively (lane 8). Moreover, the extent of this
uncoupled 39-incision in the absence of XPF-ERCC1 was equal
to the sum of the excision plus uncoupled 39-incision in the
complete system (lane 3 versus 8). This suggests that 39-inci-
sion occurs at a normal level in the absence of XPF-ERCC1, the
protein responsible for 59-incision. A second significant point in
Fig. 4A is that in the absence of RPA (lane 9), there was no
detectable (,5% of the signals in lanes 3 and 8) excision or
uncoupled 59- or 39-incision, indicating that RPA is required for
both incisions.
XPC-HHR23B Is Not Required for Excision of Certain Le-
sions—Human XP-C mutant cell lines exhibit a unique bio-
chemical phenotype. Even null XP-C mutants repair thymine
dimers and (6-4) photoproducts of the template strand of the
actively transcribing genes at a normal rate (Venema et al.,
1991; van Hoffen et al., 1995). To accommodate these observa-
tions, it was hypothesized either that a stalled RNA polymer-
ase substitutes for XPC in the assembly of excision nuclease or
that the structure of damaged DNA in the stalled complex
obviates the need for the XPC protein. When we tested a
cholesterol-containing substrate (cholesterol-B) (Fig. 2B) in ad-
dition to the thymine dimer substrate in reconstitution exper-
iments, a surprising result was obtained. Fig. 4B shows that, in
contrast with the thymine dimer, the cholesterol-B lesion was
excised in the absence of XPC (lane 7). However, the level of
excision without XPC was lower than that of the complete
system, and omission of XPC caused more degradation of the
substrate than the omission of any of the other factors. Simi-
larly, omission of XPC and XPF-ERCC1 led to extensive deg-
radation without excision (lane 3), consistent with the notion
that in the absence of XPF-ERCC1, 39-incision was made.
These results suggest that XPC is not required for either the 39-
or the 59-incision with this particular substrate. Without the
protection of XPC, the incised DNA as well as the full-length
FIG. 2. Substrates used in this study. A, and B, the two types of
cholesterol substrates. C, thymine dimer. All of these lesions were
incorporated into 140-base pair duplexes as described under “Experi-
mental Procedures.” For convenience, lesion structures shown in A and
B were termed cholesterol-A and cholesterol-B, respectively. D and E,
schematic drawings of the full-length duplex substrates for the thymine
dimer and cholesterol and the oligonucleotides (a–d) used for substrate
construction.
FIG. 3. Excision of cholesterol-A lesion and thymine dimer by
reconstituted human excision nuclease. Upper panels, quantita-
tive analyses of the data. The percent of the input substrate that was
either nicked 39 only or excised is plotted. Lower panels, sequencing gels
showing the excision of cholesterol-A and the thymine dimer. Choles-
terol was excised mainly in the form of 26–28-nucleotide-long oli-
gomers; the thymine dimer was excised in the form of 28–32-nucleotide-
long oligomers. The reaction mixtures contained 1 nM DNA substrate
and the following concentrations of the repair factors: 20 nM XPA, 0.2
nM TFIIH, 1.6 nM XPC, 0.5 nM XPG, 0.5 nM XPF-ERCC1, and 100 nM
RPA.
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substrate were degraded possibly by the nonspecific nuclease
activity of XPG or XPF-ERCC1. The phenomenon of XPC-
independent excision of cholesterol-B lesion, however, cannot
be entirely attributed to the cholesterol molecule because the
excision of a second cholesterol-containing substrate, cholester-
ol-A lesion (Fig. 2A), does depend on XPC (data not shown).
Without solving the molecular structure of these various sub-
strates, it is impossible to determine why excision of cholester-
ol-B lesion is XPC-independent. However, the observation that
this lesion is excised in the absence of XPC and of transcription
may be taken as evidence for the notion that in transcription-
coupled repair, the structure of the DNA in the stalled complex
rather than RNA polymerase per se enables the excision nucle-
ase to assemble and excise damage from the template strand at
an essentially normal rate.
Since these results were quite unexpected, we considered the
possibility that low level contaminant XPC in our other factors
may be responsible for the excision nuclease activity reconsti-
tuted without XPC-HHR23B. The mixture of other HeLa cell-
derived factors (TFIIH, XPG, and XPF-ERCC1) was tested for
XPC contamination by Western analysis. With an assay capa-
ble of detecting 10 pg of XPC in our reaction mixture, no XPC
was detectable (Fig. 1B). This enables us to rule out the pres-
ence of contaminating XPC that would support the excision of
cholesterol-B lesion by XPC-omitted reconstitution reaction.
An implication emerging from these observations is that with
certain substrates or with all substrates in special structures
as exist during transcription, XPC is not needed for excision
nuclease activity.
Assembly of Excision Nuclease—Although the properties of
the excision nuclease subunits in isolation have led to plausible
models for the assembly of this complex enzyme system
(Tanaka and Wood, 1994; Sancar, 1995; Park et al., 1995a),
direct evidence for these models was limited. The data pre-
sented in Fig. 4A (lane 8) reveal that the 39-incision that is
made by XPG (Harrington and Lieber, 1994; O’Donovan et al.,
1994; Matsunaga et al., 1995) occurred to the normal extent
without XPF-ERCC1, demonstrating that the five other frac-
tions can assemble at the lesion site without XPF-ERCC1.
Consequently, XPF-ERCC1 may be the last factor to join the
assembly.
In contrast, no 59-incision was observed in the absence of
XPG (Fig. 4A, lane 7). Two explanations were considered for
this finding. (i) XPG must be present to form the preincision
complex; and (ii) the 59-incision made by XPF-ERCC1 depends
on the presence of the 39-incision made by XPG, but not on the
actual existence of XPG in the preincision complex. Previous
studies have shown that inhibition of 39-incision by anti-XPG
antibodies does not interfere with the 59-incision, indicating
that the formation of 59-incision is not dependent on the pro-
duction of the 39-nick (Matsunaga et al., 1995). Hence, the
failure to observe 59-incision in the absence of XPG might be
due to the fact that XPG must be present in the preincision
complex to enable XPF-ERCC1 to bind and carry out the 59-
incision. To test this model, we conducted the following exper-
iment. CFE from an XP-F or XP-G mutant cell line was mixed
with substrate that contained biotinylated nucleotides at the
39-termini. Following incubation, the substrate and preincision
complexes on the substrate were removed from the unbound
cellular proteins using streptavidin-attached magnetic beads.
An XP-G or XP-F cell-free extract was then added to the im-
mobilized complexes isolated from XP-F or XP-G CFE, respec-
tively. The results reveal that addition of the XP-G extract
(which contains XPF-ERCC1) or purified XPF-ERCC1 to the
DNA-protein complex isolated from the XP-F extract produced
excision (Fig. 5, lane 2). In contrast, addition of XP-F CFE to
the complexes pulled down from the XP-G extract in the same
manner did not result in excision (lane 4). From these data, we
conclude that XPG enters the preincision complex before XPF
FIG. 4. Differential requirement for excision of thymine dimer
(T<>T) and cholesterol-B lesions. A, excision of T,.T. The posi-
tions of the excision product and uncoupled 39-incision are indicated.
Substrate (3.5%) was excised, and 1.5% of the substrate contained
uncoupled 39-incision in the complete system (lane 3). In the reaction
without XPF-ERCC1 (lane 8), 5% of the substrate contained an uncou-
pled 39-nick. B, excision of cholesterol-B lesion. The positions of the
main excision products are shown by a bracket. The level of excision in
the area indicated by the bracket was 3.5% in the complete system (lane
4) and 2.7% in the reaction lacking XPC (lane 7). Lane 1, size markers
(M) in nucleotides.
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and that XPG is required for positioning of the XPF-ERCC1
nuclease in nicking at the 59-side of damage.
Order of Incision—The finding that XPG, along with other
factors except XPF-ERCC1, can make the 39-incision raised the
possibility that the 39-incision may precede the 59-incision.
However, in a previous study, it was found that anti-XPG
antibodies inhibited 39-incision while having only a modest
effect on 59-incision, whereas anti-ERCC1 antibodies inhibited
both 39- and 59-incisions to the same extent (Matsunaga et al.,
1995). These observations are consistent with 59-incision pre-
ceding and being necessary for 39-incision. To investigate the
order of incision directly, a kinetic experiment was performed
to examine the appearance of the two incisions. The lower panel
of Fig. 6 shows the results of this experiment, and the upper
panel shows the quantitations of uncoupled 39-nicks and exci-
sion that represents the 59-nicks coupled to 39-nicks on inter-
nally radiolabeled substrate. At early time points (lanes 3 and
4), 39-nicks started to build up, while no 59-incision (excision)
was detectable, suggesting that 39-incision happens first. While
the uncoupled 39-nicks seemed to level off after 30 min, dual
incision (excision) continued to accumulate. The results of ki-
netic experiments over a much longer period of time using the
same T,.T substrate were as shown in Fig. 3: the level of
uncoupled 39-nicks remained approximately constant at ,5%,
whereas the dual incision went up to 30%. Although the lag
time between the two 39- and 59-incisions seemed to vary some-
what (see the level of T,.T excision at the 60-min time point
in Figs. 3 and 6), the appearance of 39-incision ahead of
59-incision has been reproducible. Thus, analogous to the
bacterial excision nuclease (Lin and Sancar, 1992), we conclude
that in human excision nuclease, the 39-incision precedes the
59-incision.
Role of TFIIH and CDK-activating Kinase in Excision—The
general transcription factor TFIIH is an essential general ex-
cision repair factor (Drapkin et al., 1994; Schaeffer et al., 1994;
Wang et al., 1994). Its polypeptide composition ranges from 5 to
10 depending on the purification procedure (Gerard et al., 1991;
Conaway and Conaway, 1993; Zawel and Reinberg, 1995). The
precise function of TFIIH in excision nuclease is not known;
however, two of its subunits, XPB and XPD, have helicase
activities that are thought to be important for locally unwind-
ing the duplex and thus targeting the nuclease subunits to
their proper sites. Indeed, it has been shown that excision is
absolutely dependent on ATP hydrolysis (Svoboda et al., 1993).
However, it was not clear whether both 39- and 59-incisions
required ATP hydrolysis. To answer this question, we per-
formed an incision assay with 59-terminally labeled DNA in a
standard reaction mixture with an increasing amount of
ATPgS. Fig. 7 shows that the poorly hydrolyzable ATPgS com-
peted with ATP and inhibited both 59- and 39-incisions, ruling
out the possibility that uncoupled single incision may occur
without ATP hydrolysis. This lends credence to the notion that
TFIIH helicase-directed unwinding of DNA (not just ATP bind-
ing-induced conformational change) is required for targeting
the nuclease subunits and enabling them to attack the appro-
priate phosphodiester bonds.
Recently, the CDK7-cyclin H pair was found to be a constit-
uent of TFIIH and to be responsible for its kinase activity (Roy
FIG. 5. Preincision complex formation with extract lacking
XPF, but not with extract deficient in XPG. Cell-free extracts from
XP-F (GM08437A) or a Chinese hamster ovary cell line defective in XPG
(UV135) were mixed with internally radiolabeled cholesterol-A sub-
strate with a 39-biotin tag. The preincision DNA-protein complex was
isolated by the pull-down method as described under “Experimental
Procedures” and complemented with either a second mutant extract or
purified repair factor. Lane 1, the XP-F plus XP-G cell-free extract was
used as a positive control. Lane 2, the substrate pulled down in XP-F
CFE with streptavidin beads was incubated in XP-G CFE. Lane 3, same
as lane 2, except that purified XPF-ERCC1 (2 ng), instead of the XP-G
cell-free extract, was added to the pull-down DNA-protein complex.
Lane 4, the substrate pulled down following incubation with XP-G CFE
by beads was then incubated with XP-F CFE. The positions of the major
excision products are marked to the left of the lane 1.
FIG. 6. Order of incision. Upper panel, shown are quantitative
analyses of the data in the lower panel. Lower panel, internally radio-
labeled thymine dimer substrate was incubated with the reconstituted
excision nuclease. Aliquots were taken at the indicated time points,
quenched with 20 mg of proteinase K, and analyzed on an 8% sequenc-
ing gel. The uncoupled 39-incision appeared before the excision product,
which required both 39- and 59-incisions. Uncoupled 59-incision (which
is not observed) would have produced fragments of 88–92 nucleotides.
Lane 1, size markers (M) in nucleotides.
Reaction Mechanism of Human DNA Repair Excision Nuclease 8289
et al., 1994; Serizawa et al., 1995; Shiekhattar et al., 1995).
Furthermore, it was reported that microinjection of antibodies
to CDK7 inhibited excision repair in vivo (Roy et al., 1994),
leading to the conclusion that CDK7 was essential for excision
repair. Our purest TFIIH fraction (fraction 9 of the last Mono S
column chromatography step) contained stoichiometric CDK7
and cyclin H subunits. However, in the last purification step, a
second form of TFIIH devoid of CDK7 and cyclin H was also
obtained (fraction 10) (Fig. 8, A and B), as evidenced by immu-
noblottings using anti-CDK7 and anti-cyclin H antibodies and
a kinase assay to detect the phosphorylation of a tetrahep-
tapeptide repeat (YSPTSPS) of the carboxyl-terminal domain
(CTD) of RNA polymerase II. Fig. 8C shows that the CDK-
activating kinase-lacking TFIIH fraction 10 has ,2% of the
CTD peptide kinase activity of the TFIIH holoenzyme (faction
9), consistent with the notion that CDK7-cyclin H is responsi-
ble for the kinase activity of TFIIH. To ensure that CDK7-
cyclin H was not in our other HeLa cell-purified basal repair
factors (XPC, XPG, and XPF-ERCC1), we performed the same
kinase assay on both individual factors and a combination of
the entire set and found no indication of CTD peptide kinase
activity (data not shown). When the two forms were tested for
reconstitution of excision nuclease activity, no difference was
detected between the form containing CDK7-cyclin H and the
fraction without it (Fig. 8D). Thus, we conclude that the CDK7-
cyclin H pair neither is necessary for nor interferes with the
repair function of TFIIH.
Fates of Excised Oligomer and Gapped DNA—Following the
dual incision in bacterial excision repair, two of the repair
proteins, the excised oligomer, and the gapped DNA remain
associated in a complex. This complex is later disrupted by
repair synthesis proteins, which ultimately fill the repair gap
and restore the duplex (Orren et al., 1992). Given the bacterial
precedent, we wished to know if in humans the excision nucle-
ase (or a subassembly of it), the excised oligomer, and the
gapped DNA remain in a postexcision complex prior to the
disruption by repair synthesis proteins. Internally radiolabeled
substrate with a terminal biotin tag was incubated with either
E. coli (A)BC excinuclease or human excision nuclease, and
then the unrepaired substrate and gapped DNA were removed
from the reaction mixture by using streptavidin-attached mag-
netic beads. Both the streptavidin-bound fraction and the un-
bound material were analyzed on a sequencing gel. Fig. 9
shows that in this experimental system, .90% of the DNA was
biotinylated and removed from solution by the streptavidin
beads (lanes 2 and 3). When the E. coli excinuclease products
were analyzed in this manner, it was found that all of the
excised oligomer remained associated with the gapped duplex
(lane 4 versus 5). This is in agreement with previous studies
that showed that after incision the UvrB and UvrC subunits
and the excised oligomer remain in the same complex with the
gapped DNA (Caron et al., 1985; Orren et al., 1992). To our
surprise, with the human excision nuclease system, ;90% of
the excised oligomer was left in the streptavidin-unbound frac-
tion, showing that the excised oligomer is off the gapped duplex
DNA (lane 6 versus 7). Thus, unlike the bacterial system, in
humans, the excised oligomer is released without the aid of
repair synthesis proteins.
To investigate whether or not the excised oligomer and the
gapped DNA were also released from the excision nuclease or
its subunits or subassemblies, we conducted an excision assay
using a mixture of internally and 59-terminally labeled sub-
strates. The reaction products were analyzed on nondenaturing
polyacrylamide gels. As shown in Fig. 10A, three major bands
(bands a–c) were observed in addition to free substrate (lane 2).
The DNA within these bands was analyzed on sequencing gels.
FIG. 7. ATP hydrolysis is required for both 3*- and 5*-incisions.
To the excision assay containing 2 mM ATP were added the indicated
amounts of ATPgS (Pharmacia Biotech Inc.), and the reaction was
carried out for 60 min at 30 °C with 59-terminally radiolabeled choles-
terol-A substrate. Lane 1, size markers (M) in nucleotides.
FIG. 8. Roles of TFIIH subunits in excision. A, column profile of
the final Mono S column chromatography step visualized by silver-
stained SDS-PAGE (10%). B, analysis of the same fractions by immu-
noblotting using a mixture of anti-XPB, anti-XPD, anti-p62, anti-CDK7,
and anti-cyclin H (CycH) antibodies. C, CTD peptide kinase assay with
holo-TFIIH and core TFIIH using increasing amounts of fractions 9 and
10. Each microliter of TFIIH fractions 9 and 10 contained ;1 ng of
protein as determined by the dye binding protein assay (Bio-Rad).
Kinase assay was conducted as described by Aprelikova et al. (1995). D,
excision assays with holo-TFIIH and core TFIIH. The positions of the
major excision products are indicated. M, size markers in nucleotides;
FT, flow-through fractions.
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Fig. 10B (lane 5) shows that the slowest migrating band (band
a) contained unrepaired DNA and DNA with an uncoupled
39-nick. The middle band (band b) contained the excised oli-
gomer, but not gapped DNA, as evidenced by the lack of 50–
51-nucleotide-long fragments generated from the 59-labeled
DNA by 59-incision (lane 6 versus 7). Finally, the fastest mi-
grating DNA-protein complex (band c) contained the gapped
DNA and no excised oligomer (lane 7). To ensure that band c
was not protein-free gapped DNA with anomalous migration
due to its unusual structure, the same reaction mixture was
treated with proteinase K prior to analysis by native gels. As
seen in Fig. 10A (lane 3), under these conditions, only two
closely migrating bands were observed: the unrepaired DNA
and a second, fainter band (band e). Analysis of band e on a
sequencing gel revealed that it contained the gapped DNA, as
evidenced by the presence of 50–51-nucleotide-long labeled
oligomers (Fig. 10B, lane 9). Therefore, the retarded band c in
lane 2 represents a protein-bound form of gapped DNA.
In conclusion, these experiments reveal that even though the
excised oligomer is released from the gapped DNA, both the
excised oligomer and the gapped DNA are complexed with
proteins. Currently, we do not know the identities of the pro-
teins in these complexes. However, it is important that the
excision gap is protected by repair proteins from nonspecific
nucleases until repair synthesis takes place.
DISCUSSION
Using the excision repair factors purified to homogeneity, we
have reconstituted human excision repair nuclease and inves-
tigated the roles of the individual components and the sequence
of events in the excision reaction. We have used synthetic
substrates with either a natural (thymine dimer) or an artifi-
cial (cholesterol) lesion at a unique site for these studies. Thus,
the combination of repair factors of high purity and of uniform
substrate has enabled us to probe the reaction mechanism in
considerable detail. In previous reconstitution studies of both
human (Mu et al., 1995; Aboussekhra et al., 1995) and yeast
(Guzder et al., 1995) excision nucleases, the efficiency of the
reconstituted systems was very low. Typically, ,1% of the
substrate was repaired. Such low efficiency raised the possibil-
ity that the reconstituted systems lacked some additional fac-
tors required for optimal activity. The present study shows
that, in fact, no additional factors are required for the basal
excision reaction. By having sufficient quantities of all of the
repair factors, we were able to optimize the concentration of
each in the reaction mixture so that the excision rate and
extent were comparable to the in vivo values. Thus, we consider
the results obtained with this system to be applicable to exci-
sion repair in vivo. In the following text, we attempt to address
the roles of the various components in light of results presented
in this paper and previous studies and present a reaction
scheme (Fig. 11) consistent with existing data on human nu-
cleotide excision repair.
Role of RPA—Using anti-RPA antibodies and cell-free ex-
tract, it was found that RPA was required for the repair syn-
thesis step of excision repair (Coverley et al., 1991). More
recently, it was reported that RPA was absolutely required for
FIG. 9. Human excision nuclease releases excised oligomers
from gapped duplex. The 39-terminally biotinylated, internally radio-
labeled cholesterol-A substrate 156 nucleotides in length (Huang and
Sancar, 1994; Shi et al., 1987) was incubated with E. coli or human
excision nuclease. The DNA was then pulled down with streptavidin
beads, and the streptavidin bead-bound (B) and -unbound (U) fractions
were analyzed on a sequencing gel. Lane 1, size markers (M) in nucle-
otides; lanes 2 and 3, substrate DNA incubated only in reaction buffer
and then separated by streptavidin beads; lanes 4 and 5, reaction with
the bacterial enzyme; lanes 6 and 7, reaction with the human excision
nuclease. The locations of bacterial (12–13 nucleotides) and human
(26–28 nucleotides) excision products are indicated. The excision reac-
tion with the E. coli UvrA, UvrB, and UvrC proteins was carried out as
described by Thomas et al. (1985).
FIG. 10. Analysis of postexcision complexes. A, analysis of reac-
tion products using nondenaturing PAGE. Excision reaction with a
mixture of internally and terminally labeled T,.T substrates was
performed, and the products were separated on a 4% nondenaturing
polyacrylamide gel. Lane 1, DNA alone; lane 2, total excision reaction
mixture; lane 3, total excision reaction mixture treated with proteinase
K. Nondenaturing gel electrophoresis conditions were as described by
Mu et al. (1995). B, analysis of the DNA in the DNA-protein complexes
on sequencing gels. Lane 4, size markers (M) in nucleotides; lanes 5–9,
bands a–e, respectively, from the gels shown in A. The positions of the
excision product at 29–30 nucleotides and of the 59-incision at 50–51
nucleotides are indicated. Note that due to the large amount of unre-
paired DNA, all retarded bands contained some full-length substrate as
a contaminant.
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excision of DNA damage (Mu et al., 1995). However, another
study reported that even in the absence of RPA, damage-de-
pendent nicking of substrate plasmid occurred, albeit at a
reduced proportion relative to the complete system
(Aboussekhra et al., 1995), suggesting that either one of the two
nicks could occur without RPA or that both nicks could occur
with the other components alone, but that RPA stimulated the
reaction. The results presented here clearly show that RPA is
absolutely required for both the 59- and 39-incisions. In line
with this finding, it has been found that RPA dramatically
stimulates the 59-junction incision activity of XPF-ERCC1 and
the 39-junction cutting activity of XPG.2 Given the recent re-
ports that RPA tightly binds to XPA (He et al., 1995; Matsuda
et al., 1995; Li et al., 1995) and our finding that both 39- and
59-incisions are absolutely dependent on RPA, we propose that
RPA, in combination with XPA, acts as a damage recognition
complex and directs the nuclease subunits to the proper inci-
sion sites by its specific interactions. The results obtained with
yeast reconstituted excision nuclease are in agreement with
this model. The highly purified yeast excision nuclease system
was found to be absolutely dependent on RPA for nicking of
UV-irradiated plasmid (Guzder et al., 1995).
Role of XPC—In humans, the template strand of transcribed
genes is repaired preferentially (Mellon et al., 1987). Most XP
mutants are defective in genome overall repair as well as in
strand-specific repair (Hanawalt, 1994). However, XP-C mu-
tants are exceptional. These mutants repair the template
strand of actively transcribing genes at a normal rate, while
totally lacking in repair of nontranscribed sequences (van Hof-
fen et al., 1995). It was therefore proposed that XPC can be
substituted by either another protein (e.g. RNA polymerase) or
a special DNA structure present in a RNA polymerase-stalled
complex. The results presented in this paper show that with
certain substrates, excision can occur without XPC even in the
absence of transcription. In light of these results, we propose
that the unique conformation of DNA of the stalled transcrip-
tion complex rather than RNA polymerase itself plays the
crucial role in XPC-independent repair. Interestingly, of all of
the yeast homologs of human excision repair proteins, the XPC
homolog Rad4 shows the least sequence homology (Legerski
and Peterson, 1992; Matsutani et al., 1994), and in contrast to
XP-C mutants, yeast Rad4 mutants are totally defective in
repair (Prakash et al., 1993; Friedberg et al., 1995). The precise
role of XPC is not known. However, this protein binds to DNA
nonspecifically with high affinity and avidity (Matsutani et al.,
1994)3 and interacts with TFIIH with moderate affinity (Drap-
kin et al., 1994). Furthermore, in our reconstitution experi-
ments, omission of XPC led to degradation of the damaged
strand, but not the undamaged strand (data not shown),
presumably by the exonuclease function of XPG (Habraken et
al., 1994). Thus, a plausible function for XPC is that it binds
to the damaged strand in the preincision complex and stabi-
lizes the unwound state generated by TFIIH. Following the
dual incision, XPC may protect DNA from the nuclease sub-
units of excision nuclease as well as other nonspecific cellular
nucleases.
Role of TFIIH—TFIIH is recruited to the damage site by XPA
(Park et al., 1995a). Analogous to its function in transcription,
it possibly unwinds DNA surrounding the lesion. Inhibition of
both 39- and 59-incisions by ATPgS indicates that the helicase
function of this factor (Schaeffer et al., 1993) is important for
both incisions. The unwinding activity is intrinsic to the XPB
and XPD subunits (Weeda et al., 1990; Sung et al., 1993; Weber
et al., 1990). The p44 and p34 subunits that have zinc fingers
(Humbert et al., 1994) may play a role in DNA binding. An
important question concerning TFIIH function is whether or
not its kinase component, CDK7-cyclin H, is required for its
repair activity. Roy et al. (1994) reported that microinjection of
anti-CDK7 antibodies inhibited excision repair in vivo and
concluded that CDK7 (also known as MO15) was needed for
repair. In an apparent contradiction, it was reported that in
yeast two forms of TFIIH existed, one without Kin28 and CCL1
and one with these proteins and kinase activity (Feaver et al.,
1994; Svejstrup et al., 1995). Evidence was presented that the
core TFIIH without the kinase component restored repair
activity to cell-free extracts of repair-deficient mutants
(Svejstrup et al., 1995). In humans, we found that TFIIH with
2 T. Matsunaga and A. Sancar, unpublished results. 3 J. T. Reardon and A. Sancar, unpublished results.
FIG. 11. Model for mechanism of human excision nuclease.
Damage recognition is achieved by the combination of RPA-XPA (step
1), followed by the recruitment of TFIIH and XPC-HHR23B to locally
perturb the DNA structure around the lesion in an ATP-dependent
manner (step 2). The arrival of XPG through its interaction with TFIIH
and RPA stabilizes the preincision complex and results in the 39-inci-
sion (step 3). Subsequent recruitment of XPF-ERCC1 by XPA to the
incision complex produces the 59-incision (step 4). Upon the cutting by
XPF-ERCC1 at the 59-side, the excised lesion-containing oligomer is
dissociated from the gapped duplex DNA and bound by protein (possibly
XPC), leaving behind the gapped DNA protected by RPA from nucleases
(step 5).
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or without the CDK-activating kinase subunit was equally
active in excision repair using a repair system of highly puri-
fied proteins. The fact that the CDK-activating kinase subunits
copurify with the core subunits through a seven-column puri-
fication scheme leads us to conclude that the interaction of
CDK-activating kinase with the core subunits is rather strong.
Therefore, with holo-TFIIH, we do not think that the two parts
dissociate during the excision reaction. As to the in vivo inhi-
bition of excision repair by anti-CDK7 antibodies, it may be
taken as evidence that most of the TFIIH is in the holo-TFIIH
form in vivo and that binding of the antibodies with holo-TFIIH
simply prevents its entry into the repair complex due to steric
hindrance, rather than that CDK-activating kinase or its ac-
tivity is required for excision repair.
Roles of XPG and XPF-ERCC1—These are the nuclease sub-
units of the excision nuclease system. XPG is a single strand-
specific endonuclease with preference for single- to double-
stranded DNA junctions for the strand making the transition
in the 59 to 39 direction (O’Donovan et al., 1994). The protein
also has a weak 59 to 39 exonuclease activity (Habraken et al.,
1994). Antibody inhibition experiments suggested that XPG is
the nuclease that makes the 39-incision (Matsunaga et al.,
1995), consistent with the specificity of junction cutting activ-
ity. XPF-ERCC1 is also a single strand-specific endonuclease
(Park et al., 1995b) with special affinity (stimulated by RPA)
for junctions where the single-stranded region makes the tran-
sition to double-stranded DNA in the 39 to 59 direction,2 con-
sistent with the previous finding that XPF-ERCC1 makes the
59-incision (Matsunaga et al., 1995). The biotin-streptavidin
pull-down experiments described in this paper demonstrated
that XPG is required for the formation of a stable preincision
complex. Thus, in addition to its nuclease function, XPG has a
structural role in maintaining a stable preincision complex,
which then recruits XPF-ERCC1. From an XP-F mutant cell-
free extract, a DNA-protein complex can be isolated that, upon
supplementing with wild-type XPF from a different mutant cell
extract or purified XPF protein, leads to excision. The extent of
the 39-incision observed in the defined system without XPF-
ERCC1 is equal to that of uncoupled 39-nicks plus excision by
the complete system (Fig. 4A, lanes 3 and 8), indicating that the
complex formed in the absence of XPF-ERCC1 is functionally
similar to the one formed in the presence of XPF-ERCC1. In
this regard, the human excision nuclease system differs from
the yeast excinuclease system despite numerous similarities
(including number and sequence of subunits) between the two
systems (Prakash et al., 1993; Friedberg et al., 1995): in yeast,
uncoupled 39-incision does not occur in the absence of the
Rad1-Rad10 complex, which is the structural and functional
homolog of XPF-ERCC1 (Guzder et al., 1995).
In light of the documented interactions between XPA and
XPF-ERCC1 (Li et al., 1994; Park and Sancar, 1994) and data
presented herein, it is tempting to speculate that XPA not only
participates in damage recognition, but also acts as an anchor
to recruit XPF-ERCC1 to the proper 59-incision sites. In other
words, this model predicts that XPAmust be an integral part of
the excision nuclease-DNA complex from the first step of dam-
age recognition to the step prior to 59-incision.
Human XP-F mutants exhibit a unique phenotype: shortly
after UV irradiation, these cells repair damage at 10–15% of
the normal level, but excision increases up to 60% with further
incubation. Unlike most other XP mutants (with the exception
of XP-E), XP-F cells are only moderately UV-sensitive (Cleaver
and Kraemer, 1989). Surprisingly, however, CFEs from these
mutants are totally defective in excision nuclease activity as
determined by an assay capable of detecting 0.1% of normal
excision activity (Reardon et al., 1993). In view of the results in
this paper that XPF-ERCC1 is not required for 39-incision, an
explanation can be offered for this abnormal phenotype of XP-F
cells: the other five factors of the excision nuclease assemble
and make the 39-incision, which ultimately leads to damage
removal by nonspecific 39 to 59 acting exonuclease(s). Hence,
the reaction occurs slowly compared with the normal excision.
Such an explanation, in turn, raises an important question: is
the uncoupled 39-incision a normal event during the course of
action of human excinuclease, and does it persist for a signifi-
cant length of time until the XPF-ERCC1 complex diffuses to
the lesion site and makes the 59-incision? When excision reac-
tion was carried out in HeLa CFE, futile 39-nicking was a rare
event, implicating the presence of “a mechanism” in CFE to
maintain efficient coupling of the two nicks. This mechanism of
keeping tightly coupled dual incision may be accomplished by
several means. (i) The entire set of excision repair proteins may
exist in a large complex termed “repairosome,” as has been
suggested for yeast (Svejstrup et al., 1995). (ii) XPF-ERCC1 is
actually recruited to the damage site early on, despite the
failure to obtain supporting evidence in this study. (iii) An as
yet unidentified protein can suppress 39-incision by XPG. Upon
displacement of this protein by XPF-ERCC1, both 39- and 59-
incisions occur in a concerted but nonsynchronous manner.
More experiments are needed to differentiate these models.
Postincision Reactions—In the bacterial excinuclease sys-
tem, the “excised” oligomer, the two nuclease subunits, and the
gapped DNA remain in a complex that is subsequently dis-
rupted by repair synthesis proteins. Surprisingly, in human
excinuclease, following the dual incision, the excised oligomer
is set free from the gapped DNA. However, both the excised
oligomer and the gapped DNA are bound to specific repair
proteins, as evidenced by the presence of unique DNA-protein
complexes following dual incision. This is especially important
for protection of gapped DNA from attack by nonspecific nucle-
ases, which would otherwise produce double strand breaks. At
present, we do not know the identity of the proteins associated
with either the excised oligomer or the gapped DNA. However,
of special note is the intriguing observation that the excised
29-mer complex has slower mobility than the DNA-protein
complex of the gapped 140-mer product. Given the 30-nucleo-
tide binding pocket of human RPA (Kim et al., 1994), it is quite
conceivable that the gapped DNA is associated with RPA alone
and thus primed for gap filling by PCNA-dependent DNA po-
lymerase d or e (Shivji et al., 1992; Nichols and Sancar, 1992).
The excised oligomer might be complexed with XPC since it
undergoes degradation in the reactions where excision takes
place without XPC. Future work is needed to understand the
postincision events and the precise composition of excision
nuclease at various stages.
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